1. Home
  2. MCS vs ETON Comparison

MCS vs ETON Comparison

Compare MCS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$16.07

Market Cap

482.2M

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.73

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCS
ETON
Founded
1935
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.2M
498.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MCS
ETON
Price
$16.07
$16.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$24.00
$29.67
AVG Volume (30 Days)
257.2K
272.1K
Earning Date
10-31-2025
11-06-2025
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$712,239,000.00
$70,316,000.00
Revenue This Year
$10.32
$113.27
Revenue Next Year
$5.27
$36.70
P/E Ratio
$65.59
N/A
Revenue Growth
6.27
102.77
52 Week Low
$12.85
$11.09
52 Week High
$22.55
$23.00

Technical Indicators

Market Signals
Indicator
MCS
ETON
Relative Strength Index (RSI) 60.44 48.52
Support Level $14.63 $16.13
Resistance Level $15.79 $17.05
Average True Range (ATR) 0.45 0.75
MACD 0.02 0.13
Stochastic Oscillator 90.79 79.66

Price Performance

Historical Comparison
MCS
ETON

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: